Correlation of receptor activator of nuclear factor kappa b (RANK) expression in breast cancer (BC) at the time of diagnosis with recurrence-free survival (RFS) and risk of bone-dominant metastases (BDM) in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657).
Jiali Li
No relevant relationships to disclose
Christina Yau
No relevant relationships to disclose
Michael Campbell
No relevant relationships to disclose
Laura Esserman
No relevant relationships to disclose
John W. Park
No relevant relationships to disclose
Hope S. Rugo
No relevant relationships to disclose